onkoview.com
  • Home
  • contact
  • ···
        • YouTube
    onkoview.com
    • Home
    • contact
    • ···
          • YouTube
      onkoview.com
      • Home
      • contact

      Layout F

      Clonal evolution of tumours

      7 months ago

      Molecular action of p53 in carcinogenesis

      8 months ago

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      8 months ago

      The cell cycle – Part 1: Phases and checkpoints

      8 months ago

      The cell cycle – Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

      7 months ago

      Apoptosis

      8 months ago

      Oncogenic activation of receptor tyrosine kinases

      8 months ago

      The EGF receptor tyrosine protein kinases

      7 months ago

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      7 months ago

      Layout F 2/3

      Clonal evolution of tumours

      7 months ago

      Molecular action of p53 in carcinogenesis

      8 months ago

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      8 months ago

      The cell cycle – Part 1: Phases and checkpoints

      8 months ago

      The cell cycle – Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

      7 months ago

      Apoptosis

      8 months ago

      Layout F 1/3

      Oncogenic activation of receptor tyrosine kinases

      8 months ago

      The EGF receptor tyrosine protein kinases

      7 months ago

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      7 months ago

      Layout F (with E as starter)

      Video
      Onkoview 2010

      Oncogenic activation of receptor tyrosine kinases

      42 views
      1 min read
      Video
      Onkoview 2015

      The EGF receptor tyrosine protein kinases

      38 views
      1 min read
      Video
      Onkoview 2015

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      70 views
      1 min read

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 1: Normal and aberrant karyograms

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 2: The Philadelphia chromosome

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 3: The BCR-ABL fusion protein

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 4: Therapy of tumors with BCR-ABL1 fusion proteins

      7 months ago

      The MAP-Kinase (MAPK) signalling pathway

      8 months ago

      Layout F (with load more button)

      Oncogenic activation of receptor tyrosine kinases

      8 months ago

      The EGF receptor tyrosine protein kinases

      7 months ago

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      7 months ago

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 1: Normal and aberrant karyograms

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 2: The Philadelphia chromosome

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 3: The BCR-ABL fusion protein

      7 months ago

      BCR-ABL1 and the Philadelphia chromosome – Part 4: Therapy of tumors with BCR-ABL1 fusion proteins

      7 months ago

      The MAP-Kinase (MAPK) signalling pathway

      8 months ago
      Load More

      THE AUTHORS:
      Prof. Dr. med. Christoph Wagener
      Prof. Dr. med. Dr. rer nat. Oliver Müller
      VIDEO PRODUCTION:
      David Lengersdorf
      VOICEOVER :
      Ellen Wagner

      Youtube channel

      Most Viewed

      Clonal evolution of tumours

      112 views

      Molecular action of p53 in carcinogenesis

      86 views

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      63 views

      Copyright © 2022. Created by onkoview. Powered by artindustries. Privacy policy.